213 related articles for article (PubMed ID: 24064216)
1. Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70.
Kapoor K; Bhatnagar J; Chufan EE; Ambudkar SV
J Biol Chem; 2013 Nov; 288(45):32622-32636. PubMed ID: 24064216
[TBL] [Abstract][Full Text] [Related]
2. Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4.
Gautherot J; Durand-Schneider AM; Delautier D; Delaunay JL; Rada A; Gabillet J; Housset C; Maurice M; Aït-Slimane T
J Biol Chem; 2012 Feb; 287(7):5070-8. PubMed ID: 22184139
[TBL] [Abstract][Full Text] [Related]
3. Processing mutations located throughout the human multidrug resistance P-glycoprotein disrupt interactions between the nucleotide binding domains.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2004 Sep; 279(37):38395-401. PubMed ID: 15247215
[TBL] [Abstract][Full Text] [Related]
4. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
Chufan EE; Kapoor K; Sim HM; Singh S; Talele TT; Durell SR; Ambudkar SV
PLoS One; 2013; 8(12):e82463. PubMed ID: 24349290
[TBL] [Abstract][Full Text] [Related]
5. The dileucine motif at the COOH terminus of human multidrug resistance P-glycoprotein is important for folding but not activity.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2005 Jan; 280(4):2522-8. PubMed ID: 15542593
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
[TBL] [Abstract][Full Text] [Related]
7. Locking intracellular helices 2 and 3 together inactivates human P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 2014 Jan; 289(1):229-36. PubMed ID: 24275649
[TBL] [Abstract][Full Text] [Related]
8. Insertion of an arginine residue into the transmembrane segments corrects protein misfolding.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2006 Oct; 281(40):29436-40. PubMed ID: 16926162
[TBL] [Abstract][Full Text] [Related]
9. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
Chufan EE; Kapoor K; Ambudkar SV
Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1).
Sajid A; Lusvarghi S; Chufan EE; Ambudkar SV
PLoS One; 2018; 13(9):e0204693. PubMed ID: 30265721
[TBL] [Abstract][Full Text] [Related]
11. Transport activity and surface expression of the Na+-Ca2+ exchanger NCX1 are inhibited by the immunosuppressive agent cyclosporin A and by the nonimmunosuppressive agent PSC833.
Kimchi-Sarfaty C; Kasir J; Ambudkar SV; Rahamimoff H
J Biol Chem; 2002 Jan; 277(4):2505-10. PubMed ID: 11700317
[TBL] [Abstract][Full Text] [Related]
12. Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.
Vahedi S; Chufan EE; Ambudkar SV
Biochem Pharmacol; 2017 Nov; 143():53-64. PubMed ID: 28728917
[TBL] [Abstract][Full Text] [Related]
13. Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 2015 Dec; 290(49):29389-401. PubMed ID: 26507655
[TBL] [Abstract][Full Text] [Related]
14. Rescue of folding defects in ABC transporters using pharmacological chaperones.
Loo TW; Bartlett MC; Clarke DM
J Bioenerg Biomembr; 2005 Dec; 37(6):501-7. PubMed ID: 16691490
[TBL] [Abstract][Full Text] [Related]
15. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
[TBL] [Abstract][Full Text] [Related]
16. Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein.
Sajid A; Lusvarghi S; Murakami M; Chufan EE; Abel B; Gottesman MM; Durell SR; Ambudkar SV
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29609-29617. PubMed ID: 33168729
[TBL] [Abstract][Full Text] [Related]
17. Some new aspects of molecular mechanisms of cyclosporin A effect on immune response.
Zav'yalov VP; Denesyuk AI; Lundell J; Korpela T
APMIS; 1995 Jun; 103(6):401-15. PubMed ID: 7546642
[TBL] [Abstract][Full Text] [Related]
18. Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers.
Ansermot N; Rebsamen M; Chabert J; Fathi M; Gex-Fabry M; Daali Y; Besson M; Rossier M; Rudaz S; Hochstrasser D; Dayer P; Desmeules J
Drug Metab Lett; 2008 Apr; 2(2):76-82. PubMed ID: 19356075
[TBL] [Abstract][Full Text] [Related]
19. Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.
Ritchie TK; Kwon H; Atkins WM
J Biol Chem; 2011 Nov; 286(45):39489-96. PubMed ID: 21937435
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast.
Hemenway CS; Heitman J
J Biol Chem; 1996 Aug; 271(31):18527-34. PubMed ID: 8702500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
